Source: Eur Respir J, 57 (5) 2001877; 10.1183/13993003.01877-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Hee-Young Yoon, Sun-Young Kim, Ok-Jin Kim, Jin Woo Song. Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis. Eur Respir J, 57 (5) 2001877; 10.1183/13993003.01877-2020

Member's Comments

No comment yet.

Related content which might interest you: Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016 Slope of exercise ventilation to carbon dioxide production in patients with pulmonary arterial hypertension, either primary or associated with connective tissue disease Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 Association between exposure to air pollution and mortality in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Is chronic exposure to air pollutants a risk factor for the development of idiopathic pulmonary fibrosis? Source: Eur Respir J, 51 (1) 1702663; 10.1183/13993003.02663-2017 Year: 2018 Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure Source: Eur Respir J 2014; 43: 1124-1131 Year: 2014 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2012; 39: 125-132 Year: 2012 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2011; 39: 125-132 Year: 2012 Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 A prothrombotic state is associated with increased mortality in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Ventilatory inefficiency relative to oxygen uptake and carbon dioxide output are independent predictors of mortality in pulmonary arterial hypertension Source: Annual Congress 2013 –Respiratory physiology in health and disease Year: 2013 Noninvasive positive pressure ventilation using helium:oxygen versus air:oxygen in acute respiratory failure in chronic obstructive pulmonary disease patients exposed to sulfur mustard Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions Year: 2008 Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012 PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019